nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—PTGS1—malignant glioma	0.506	0.636	CbGaD
Lumiracoxib—PTGS2—malignant glioma	0.289	0.364	CbGaD
Lumiracoxib—CYP1A2—Carmustine—malignant glioma	0.115	1	CbGbCtD
Lumiracoxib—Tolmetin—CXCL8—malignant glioma	0.00144	0.156	CrCbGaD
Lumiracoxib—Bromfenac—PTGS1—malignant glioma	0.00109	0.119	CrCbGaD
Lumiracoxib—Diclofenac—CYP2C18—malignant glioma	0.000826	0.09	CrCbGaD
Lumiracoxib—Diclofenac—CXCL8—malignant glioma	0.000791	0.0861	CrCbGaD
Lumiracoxib—Tolmetin—PTGS1—malignant glioma	0.000733	0.0798	CrCbGaD
Lumiracoxib—Meclofenamic acid—PTGS1—malignant glioma	0.000722	0.0787	CrCbGaD
Lumiracoxib—Bromfenac—PTGS2—malignant glioma	0.000623	0.0679	CrCbGaD
Lumiracoxib—Diclofenac—CYP2B6—malignant glioma	0.000613	0.0668	CrCbGaD
Lumiracoxib—Mefenamic acid—PTGS1—malignant glioma	0.000562	0.0612	CrCbGaD
Lumiracoxib—Tolmetin—PTGS2—malignant glioma	0.000419	0.0456	CrCbGaD
Lumiracoxib—Meclofenamic acid—PTGS2—malignant glioma	0.000413	0.045	CrCbGaD
Lumiracoxib—Diclofenac—PTGS1—malignant glioma	0.000404	0.044	CrCbGaD
Lumiracoxib—Mefenamic acid—PTGS2—malignant glioma	0.000321	0.035	CrCbGaD
Lumiracoxib—Diclofenac—PTGS2—malignant glioma	0.000231	0.0251	CrCbGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—EGFR—malignant glioma	4.98e-05	0.000611	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	4.95e-05	0.000608	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ASMT—malignant glioma	4.95e-05	0.000608	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	4.94e-05	0.000606	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	4.88e-05	0.000599	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.84e-05	0.000594	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—SPHK1—malignant glioma	4.82e-05	0.000592	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.8e-05	0.000589	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TNF—malignant glioma	4.74e-05	0.000582	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—IDH2—malignant glioma	4.73e-05	0.00058	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CYP2C18—malignant glioma	4.73e-05	0.00058	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—BCAN—malignant glioma	4.65e-05	0.000571	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	4.64e-05	0.00057	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.46e-05	0.000547	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.46e-05	0.000547	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYP2B6—malignant glioma	4.44e-05	0.000545	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	4.43e-05	0.000544	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—COX8A—malignant glioma	4.23e-05	0.000519	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TP53—malignant glioma	4.18e-05	0.000513	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	4.16e-05	0.000511	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.1e-05	0.000503	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—IDH1—malignant glioma	4.06e-05	0.000499	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.06e-05	0.000498	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.97e-05	0.000487	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HEY2—malignant glioma	3.94e-05	0.000484	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—SPHK1—malignant glioma	3.93e-05	0.000483	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.92e-05	0.000481	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—COX8A—malignant glioma	3.86e-05	0.000473	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYP2C18—malignant glioma	3.85e-05	0.000473	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IDH1—malignant glioma	3.85e-05	0.000473	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GSTT1—malignant glioma	3.82e-05	0.000469	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.78e-05	0.000464	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	3.76e-05	0.000462	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—IDH2—malignant glioma	3.75e-05	0.00046	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HEY1—malignant glioma	3.65e-05	0.000448	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.63e-05	0.000446	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ASMT—malignant glioma	3.59e-05	0.000441	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTGS1—malignant glioma	3.58e-05	0.00044	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.57e-05	0.000438	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HIST1H3B—malignant glioma	3.55e-05	0.000435	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.54e-05	0.000434	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP2B6—malignant glioma	3.53e-05	0.000433	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.51e-05	0.000431	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.46e-05	0.000425	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.45e-05	0.000423	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.39e-05	0.000415	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—BCAN—malignant glioma	3.38e-05	0.000415	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—BCHE—malignant glioma	3.33e-05	0.000409	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.31e-05	0.000406	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—COX8A—malignant glioma	3.29e-05	0.000404	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—SLC5A5—malignant glioma	3.29e-05	0.000404	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ASMT—malignant glioma	3.28e-05	0.000402	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—JAG2—malignant glioma	3.24e-05	0.000397	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—IDH1—malignant glioma	3.23e-05	0.000396	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.22e-05	0.000396	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.2e-05	0.000393	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.2e-05	0.000393	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.19e-05	0.000392	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—SPHK1—malignant glioma	3.12e-05	0.000383	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GSTT1—malignant glioma	3.12e-05	0.000382	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.11e-05	0.000382	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—BCAN—malignant glioma	3.08e-05	0.000378	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.08e-05	0.000378	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP2C18—malignant glioma	3.06e-05	0.000375	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.94e-05	0.000361	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.94e-05	0.000361	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.91e-05	0.000357	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.88e-05	0.000354	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.84e-05	0.000349	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ASMT—malignant glioma	2.8e-05	0.000344	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—H3F3A—malignant glioma	2.74e-05	0.000336	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.74e-05	0.000336	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—IDH2—malignant glioma	2.72e-05	0.000334	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—BCHE—malignant glioma	2.71e-05	0.000333	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.69e-05	0.00033	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—SLC5A5—malignant glioma	2.68e-05	0.000329	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GSTP1—malignant glioma	2.65e-05	0.000325	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—BCAN—malignant glioma	2.63e-05	0.000323	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.63e-05	0.000322	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—JAG1—malignant glioma	2.58e-05	0.000317	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CAT—malignant glioma	2.58e-05	0.000316	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.57e-05	0.000315	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP2B6—malignant glioma	2.56e-05	0.000314	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.54e-05	0.000311	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.54e-05	0.000311	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FBXW7—malignant glioma	2.53e-05	0.000311	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.51e-05	0.000308	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—IDH2—malignant glioma	2.48e-05	0.000305	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTT1—malignant glioma	2.47e-05	0.000304	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—NCOR1—malignant glioma	2.43e-05	0.000299	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.4e-05	0.000295	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—IDH1—malignant glioma	2.34e-05	0.000288	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.34e-05	0.000288	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.34e-05	0.000287	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PTGS1—malignant glioma	2.32e-05	0.000284	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.31e-05	0.000283	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SPHK1—malignant glioma	2.27e-05	0.000278	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP2C18—malignant glioma	2.22e-05	0.000273	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.19e-05	0.000269	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GSTP1—malignant glioma	2.16e-05	0.000265	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—BCHE—malignant glioma	2.15e-05	0.000264	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—IDH1—malignant glioma	2.14e-05	0.000262	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—SLC5A5—malignant glioma	2.13e-05	0.000261	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—IDH2—malignant glioma	2.12e-05	0.000261	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CAT—malignant glioma	2.1e-05	0.000258	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.09e-05	0.000257	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SPHK1—malignant glioma	2.07e-05	0.000254	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP2C18—malignant glioma	2.03e-05	0.000249	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.01e-05	0.000247	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2e-05	0.000246	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP2B6—malignant glioma	2e-05	0.000245	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CAV1—malignant glioma	1.98e-05	0.000244	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NCOR1—malignant glioma	1.98e-05	0.000244	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN2B—malignant glioma	1.98e-05	0.000243	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.91e-05	0.000234	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.91e-05	0.000234	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.9e-05	0.000233	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HES1—malignant glioma	1.89e-05	0.000232	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NCOR1—malignant glioma	1.88e-05	0.000231	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.84e-05	0.000226	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—IDH1—malignant glioma	1.83e-05	0.000224	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CG—malignant glioma	1.81e-05	0.000222	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PDGFRA—malignant glioma	1.8e-05	0.000221	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTT1—malignant glioma	1.8e-05	0.00022	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SPHK1—malignant glioma	1.77e-05	0.000217	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PPARG—malignant glioma	1.74e-05	0.000214	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.74e-05	0.000213	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.74e-05	0.000213	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.73e-05	0.000212	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTP1—malignant glioma	1.71e-05	0.00021	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTGS1—malignant glioma	1.68e-05	0.000207	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.68e-05	0.000206	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.68e-05	0.000206	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CAT—malignant glioma	1.67e-05	0.000205	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HLA-A—malignant glioma	1.66e-05	0.000203	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TERT—malignant glioma	1.66e-05	0.000203	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTT1—malignant glioma	1.64e-05	0.000201	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.63e-05	0.0002	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PDGFB—malignant glioma	1.62e-05	0.000199	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CAV1—malignant glioma	1.62e-05	0.000199	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FGFR1—malignant glioma	1.61e-05	0.000198	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CD—malignant glioma	1.59e-05	0.000195	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HIF1A—malignant glioma	1.59e-05	0.000195	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NCOR1—malignant glioma	1.58e-05	0.000193	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—BCHE—malignant glioma	1.56e-05	0.000192	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.55e-05	0.00019	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.55e-05	0.00019	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGS1—malignant glioma	1.53e-05	0.000188	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CAV1—malignant glioma	1.53e-05	0.000188	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.53e-05	0.000188	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.49e-05	0.000182	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CG—malignant glioma	1.47e-05	0.000181	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.46e-05	0.000179	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.45e-05	0.000178	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—BAD—malignant glioma	1.44e-05	0.000177	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.43e-05	0.000176	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOTCH1—malignant glioma	1.43e-05	0.000175	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—BCHE—malignant glioma	1.43e-05	0.000175	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PPARG—malignant glioma	1.42e-05	0.000175	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.41e-05	0.000173	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTT1—malignant glioma	1.4e-05	0.000172	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD80—malignant glioma	1.4e-05	0.000172	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—APC—malignant glioma	1.4e-05	0.000171	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CB—malignant glioma	1.39e-05	0.00017	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—EGF—malignant glioma	1.38e-05	0.000169	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTGS2—malignant glioma	1.37e-05	0.000168	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PTPN11—malignant glioma	1.37e-05	0.000168	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.33e-05	0.000164	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.32e-05	0.000162	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—BRAF—malignant glioma	1.31e-05	0.000161	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGS1—malignant glioma	1.31e-05	0.000161	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.31e-05	0.00016	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CD—malignant glioma	1.3e-05	0.000159	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CAV1—malignant glioma	1.28e-05	0.000158	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—AKT2—malignant glioma	1.28e-05	0.000157	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.26e-05	0.000155	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTP1—malignant glioma	1.25e-05	0.000153	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3CD—malignant glioma	1.23e-05	0.000151	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.23e-05	0.000151	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—BCHE—malignant glioma	1.22e-05	0.00015	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CAT—malignant glioma	1.21e-05	0.000149	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SLC5A5—malignant glioma	1.2e-05	0.000148	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTEN—malignant glioma	1.2e-05	0.000147	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FGF2—malignant glioma	1.18e-05	0.000144	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CG—malignant glioma	1.17e-05	0.000144	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.15e-05	0.000141	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NCOR1—malignant glioma	1.14e-05	0.00014	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.14e-05	0.00014	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTP1—malignant glioma	1.14e-05	0.000139	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CB—malignant glioma	1.13e-05	0.000139	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PPARG—malignant glioma	1.13e-05	0.000139	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.13e-05	0.000139	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTGS2—malignant glioma	1.12e-05	0.000137	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CAT—malignant glioma	1.1e-05	0.000136	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MDM2—malignant glioma	1.1e-05	0.000135	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—RAF1—malignant glioma	1.1e-05	0.000135	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ERBB2—malignant glioma	1.08e-05	0.000133	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3CB—malignant glioma	1.07e-05	0.000131	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NCOR1—malignant glioma	1.04e-05	0.000128	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CD—malignant glioma	1.03e-05	0.000126	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.84e-06	0.000121	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTEN—malignant glioma	9.76e-06	0.00012	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTP1—malignant glioma	9.7e-06	0.000119	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CAT—malignant glioma	9.44e-06	0.000116	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CAV1—malignant glioma	9.33e-06	0.000114	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PTEN—malignant glioma	9.25e-06	0.000114	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CB—malignant glioma	8.96e-06	0.00011	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NCOR1—malignant glioma	8.91e-06	0.000109	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.91e-06	0.000109	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CAV1—malignant glioma	8.5e-06	0.000104	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CG—malignant glioma	8.5e-06	0.000104	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CA—malignant glioma	8.44e-06	0.000104	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—STAT3—malignant glioma	8.27e-06	0.000102	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PPARG—malignant glioma	8.2e-06	0.000101	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.13e-06	9.97e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CG—malignant glioma	7.75e-06	9.51e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PTEN—malignant glioma	7.75e-06	9.51e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MYC—malignant glioma	7.69e-06	9.43e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—EGFR—malignant glioma	7.52e-06	9.23e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PPARG—malignant glioma	7.48e-06	9.18e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CD—malignant glioma	7.47e-06	9.17e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CAV1—malignant glioma	7.27e-06	8.92e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—KRAS—malignant glioma	7.1e-06	8.72e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.94e-06	8.52e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—AKT1—malignant glioma	6.9e-06	8.47e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CA—malignant glioma	6.88e-06	8.45e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CD—malignant glioma	6.81e-06	8.36e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CG—malignant glioma	6.62e-06	8.12e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3CA—malignant glioma	6.52e-06	8.01e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CB—malignant glioma	6.51e-06	7.99e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTGS2—malignant glioma	6.45e-06	7.92e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PPARG—malignant glioma	6.39e-06	7.84e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CB—malignant glioma	5.94e-06	7.29e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGS2—malignant glioma	5.88e-06	7.22e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CD—malignant glioma	5.82e-06	7.14e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTEN—malignant glioma	5.63e-06	6.9e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—AKT1—malignant glioma	5.62e-06	6.9e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CA—malignant glioma	5.46e-06	6.71e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—AKT1—malignant glioma	5.33e-06	6.54e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTEN—malignant glioma	5.13e-06	6.3e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CB—malignant glioma	5.07e-06	6.23e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGS2—malignant glioma	5.03e-06	6.17e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—AKT1—malignant glioma	4.46e-06	5.48e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTEN—malignant glioma	4.38e-06	5.38e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CA—malignant glioma	3.97e-06	4.87e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.62e-06	4.44e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—AKT1—malignant glioma	3.24e-06	3.98e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CA—malignant glioma	3.09e-06	3.8e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—AKT1—malignant glioma	2.96e-06	3.63e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—AKT1—malignant glioma	2.53e-06	3.1e-05	CbGpPWpGaD
